How Community Nurse Practitioners Screen for Parkinson’s Disease in the Community
Keywords:
Parkinson’s disease, Screening for Disease, Elderly/ Community nurse practitionerAbstract
Parkinson’s disease is a neurodegenerative disorder commonly found in the elderly. Patients with Parkinson’s disease typically exhibit movement problems such as bradykinesia, rigidity, unstable posture, and tremor resulting in a poor quality of life for patients and their families. Screening new Parkinson’s disease cases in the community is a challenge for community nurse practitioners because individual patients will present with unique symptoms. Therefore, clinical knowledge about Parkinson’s disease, history taking skills, physical examination skills, and observation follow up skills will assist the community nurse practitioner in detecting new cases, with referral to medical doctors for proper medical treatment. The purpose of this article is to develop an understanding of Parkinson’s disease and empower community nurse practitioner competencies such as history taking skills, physical examination skills, with a specific skill in observing movement problems necessary to identify new Parkinson’s disease cases and delay disease progression and disabilities.
References
Bhidayasiri R. Clinical Practice Guideline for Diagnosis and Management of Parkinson’s disease. Bangkok: Chulalongkorn Centre of Excellence for Parkinson's Disease & Related Disorders. Chulalongkorn Hospital. Thai Red Cross Society; 2011.
Boonrod N, Boonpeng K, Bhidayasiri R. Parkinson's Disease Nursing Handbook. Bangkok: Chulalongkorn Centre of Excellence for Parkinson's Disease & Related Disorders. Chulalongkorn Hospital. Thai Red Cross; 2016.
De Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol 2006; 5(6): 525-35.
Vernon GM. Parkinson Disease and the Nurse Practitioner: Diagnostic and Management Challenges. The Journal for Nurse Practitioners 2009; 5(3): 195-206.
Na Nakorn R. Benefits and Cautions for Health Screening. Journal of Health Systems Research 2013; 7(3): 325-30. (in Thai)
Prachublarb C. Competencies in Caring Patients with Parkinson’s Disease. J Royal Thai Army Nurses 2015; 16(1): 1-7. (in Thai)
Postuma RB, Pelletier A, Berg D, Gagnon J-F, Escudier F, Montplaisir J. Screening for prodromal Parkinson's disease in the general community: a sleep-based approach. Sleep Medicine 2016; 21: 101-5. doi.org/10.1016/j.sleep.2015.12.016.
Pellicano C, Benincasa D, Pisani V, Buttarelli FR, Giovannelli M, Pontieri FE. Prodromal non-motor symptoms of Parkinson's disease. Neuropsychiatric Disease and Treatment 2007; 3(1): 145-52.
Jost WH. Gastrointestinal dysfunction in Parkinson's Disease. Journal of the neurological sciences 2010; 289(1-2): 69-73.
Kristian W, Clare JF. Bladder Dysfunction in Parkinsonism: Mechanisms, Prevalence, Symptoms, and Management. Movement Disorders 2006; 21(6): 737-45.
Bhidayasiri R, Mekawichai P, Jitkritsadakul O, Panyakaew P, Kaewwilai L, Boonrod N, et al. Nocturnal journey of body and mind in Parkinson's disease: the manifestations, risk factors and their relationship to daytime symptoms. Evidence from the NIGHT-PD study. Journal of neural transmission (Vienna, Austria: 1996) 2014; 121 (Suppl 1): S59-68.
Burn DJ. Beyond the iron mask: Towards better recognition and treatment of depression associated with Parkinson's disease. Movement disorders 2002; 17(3): 445-54.
Aarsland D, Kurz MW. The epidemiology of dementia associated with Parkinson disease. Journal of the Neurological Sciences 2010; 289(1): 18-22.
Santos-García D, de la Fuente-Fernández R. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease. Journal of the Neurological Sciences 2013; 332(1-2): 136-40.
Abbas MM, Xu Z, Tan LC. Epidemiology of Parkinson's Disease East Versus West. Mov Disord Clin Pract 2018; 5: 14-28.
Noyce AJ, Bestwick JP, Silveira-Moriyama L, Hawkes CH, Knowles CH, Hardy J, Giovannoni G, Nageshwaran S, Osborne C, Lees AJ, Schrag A. PREDICT-PD: identifying risk of Parkinson's disease in the community: methods and baseline results. J Neurol Neurosurg Psychiatry 2014; 85(1): 31-7.
Chan DK, Hung WT, Wong A, Hu E, Beran RG. Validating a screening questionnaire for parkinsonism in Australia. J Neurol Neurosurg Psychiatry 2000; 69(1): 117-20.
Setthawatcharawanich S, Sathirapanya P, Phabphal K, Limapichat K. Short questionnaire for Parkinson's disease as a screening instrument. Clinical Neurology and Neurosurgery 2011; 113(10): 885-8.
Luevanich C. Hypertension: Pattern for Screening the Health Silent Killer. Journal of Yala Rajabhat University 2010; 5(1): 71-86. (in Thai)
Downloads
Published
How to Cite
Issue
Section
License
บทความที่ตีพิมพ์และแผนภูมิรูปภาพถือเป็นลิขสิทธิ์ของวารสารพยาบาลสาธารณสุข (Thai Public Health Nurses Association)